<DOC>
	<DOC>NCT02202239</DOC>
	<brief_summary>To explore the effect of induction and maintenance of anesthesia with etomidate on hemodynamics and oxidative stress in diabetic patients.</brief_summary>
	<brief_title>Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<criteria>Aged between 18 and 65 years; Diabetic patients preparing for elective surgery; Body mass index is between 16 and 30 kg/m2; Blood glucose is under 8.3 mmol/kg by oral antidiabetic agents or diet control; American Society of Anesthesiology (ASA) Physical Status: Ⅰ or Ⅱ; Expected operation duration is between 2 and 8 h; Signed informed consent form. Severe cardiac, cerebral, liver, kidney, lung, endocrine disease or infectious disease; Chemotherapy or immunotherapy before the surgery; Allergy to trial drug or other contraindication; Expected or history of difficult airway; Suspected abuse of narcotic analgesia; Diseases of neuromuscular system; Mentally unstable or has a mental illness; Trend of malignant hyperthermia; Pregnant or breastfeeding women; Attendance of other trial past 30 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>